Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants. - Lin PY; Zeng BS; Chen JJ; Zeng BY; Suen MW; Hung CM; Hsu CW; Stubbs B; Chen YW; Chen TY; Lei WT; Hsu SP; et al. (Journal of hematology & oncology, 2026)